Tag Archives: healthcare

The U.S. Department of Defense returns to the BIO Convention in 2016


The Joint Project Manager for Medical Countermeasure Systems (JPM-MCS), a program within the U.S. Department of Defense (DoD), is returning to the BIO International Convention this year and looking to collaborate with biopharmaceutical companies through innovative contracting arrangements that support partnerships throughout the drug development life cycle. Two programs, the Advanced Development and Manufacturing Capabilities (ADMC) and the Joint Vaccine Acquisition Program (JVAP) are on site to discuss how other transactional authority (OTA) agreements can Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

Californians Must Reject Scare Tactics, Stand Together In Support Of Innovation


This week, the BIO International Convention kicks off in San Francisco. As BIO’s President and CEO, I’m proud to bring this annual event to the Bay Area and talk about biopharmaceutical’s advances in innovation and bringing cures to those afflicted with disease. Before the campaign season arrives, it’s time to set the record straight about the value of prescription drugs and why insurance companies are demanding that you pay more out of pocket. Voters in Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Informed Perspectives: A Preview of the Personalized Medicine & Diagnostics Track


The Biotechnology Innovation Organization (BIO) has a long history of delivering impactful educational sessions about personalized medicine, and PMC is pleased to collaborate with BIO again this year to put together a Personalized Medicine & Diagnostics Track at the BIO International Convention. Touching on a variety of topics that include clinical care, investment and public policy reform, the three-day program promises to deliver informed perspectives on the field’s current direction: Tuesday, June 7 Titled “30 Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

BIO Releases Largest Study Ever on Clinical Development Success Rates


On Wednesday, BIO released the largest ever study of clinical development success rates. The study, conducted in partnership with Amplion and Biomedtracker, recorded and analyzed 9,985 clinical and regulatory phase transitions, across 1,103 companies. Using clinical trial data from the past decade, “Clinical Development Success Rates 2006-2015” compares groups of diseases, drug modalities and other attributes to generate the most comprehensive analysis, to date, of biopharmaceutical R&D success. “This study provides a wealth of information about drug development success rates Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

BIO 2016 Patient Pavilion Snapshot: Alpha-1 Project


Every year, the BIO International Convention brings together stakeholders from the health care community to discuss how we can accelerate the pace of innovation to bring new, effective treatments to patients.  In recent years, the patient voice has been amplified in the drug development process as new models for collaboration are emerging to advance therapeutic development and ensure new treatments have meaningful outcomes for patients.  To help amplify that voice at the BIO International Convention, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,